Providence Ventures

Providence Ventures is the venture arm of Providence, one of the largest non-profit health systems in the United States, headquartered in Seattle. The fund writes checks of $5M to $25M at Series A through Series C, larger than most health-system venture arms, and it operates with explicit commercial alignment to Providence’s clinical and operational priorities. Founders pitching Providence Ventures are talking to investors who can put a portfolio company in front of one of the most consequential provider buyers in the country, which often matters more than any single check.

The thesis covers digital health, health IT and healthcare software, and medical devices and medtech. The fund is particularly interested in companies addressing high-priority operational and clinical problems for large integrated health systems, including workflow automation, AI in clinical operations, virtual care, value-based care infrastructure, and devices that meaningfully change cost or quality of care. The portfolio reflects a bias toward companies that have, or can credibly build, evidence of impact inside large health systems, and Providence will often pilot a technology before investing or alongside an investment.

Check sizes of $5M to $25M let Providence participate meaningfully in Series A through Series C and occasionally lead. The geographic focus is the United States, with most companies selling into US provider organizations. Founders should expect serious questions on procurement, integration, and change management within complex health systems, and they should treat the conversation as both an investment process and a commercial conversation. The fund’s evergreen capital structure and long-tenured team allow for patient holds and follow-on investment over multiple rounds.

The team includes investors with operating, financial, and clinical backgrounds, working closely with Providence’s clinical and operational leadership. That structure gives portfolio companies access to physicians, nurses, IT leaders, and operations executives who can provide product feedback and serve as commercial champions when it makes sense. The fund has been active for over a decade and has built a reputation as a sophisticated and constructive provider-side investor.

Providence Ventures’ working style is engaged and commercial. The fund typically takes board seats or observer roles, engages on commercial strategy and provider-side go-to-market, and uses the Providence relationship to help portfolio companies design pilots, navigate procurement, and build credibility with other health systems. The fund has co-invested with leading healthcare-focused venture firms and has supported portfolio companies through public offerings and acquisitions. Founders building enterprise software, digital health, or medtech products for US health systems, and who want a sophisticated provider-side investor with real check size and a track record of constructive commercial engagement, will find Providence Ventures one of the more credible options in the category. Founders selling to non-provider buyers will find less alignment.